I-Gel in Out-of-hospital Cardiac Arrest in Norway

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

550 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-28

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this trial is to compare the effectiveness of a newer supraglottic airway method (the i-Gel), compared to current airway management practice in out-of-hospital cardiac arrests treated by Norwegian ambulance services.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intravascular ECG During Insertion of Peripheral Inserted Central-venous Catheters: Replacement for Chest X-ray?

NCT03197246

Catheterization, Peripheral Electrocardiography

COMPLETED NA

Intraosseous Versus Intravenous Vascular Access During Cardiac Arrest

NCT01119807

Cardiac Arrest

COMPLETED NA

New Method for Real-time Detection of Tissue Ischemia

NCT04893473

Ischemia Blood Circulation Disorder Carbon Dioxide +1 more

WITHDRAWN

Patient Perspective Midline Catheter in the Emergency Department

NCT05607238

Patient Satisfaction Patient Preference

WITHDRAWN NA

The Ability of Anesthesiologists Identifying Internal Jugular Vein Bilaterally by Anatomic Landmarks

NCT01607281

Internal Jugular Vein Canulation Anatomical Landmark

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Out of Hospital Cardiac Arrest

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

I-Gel

I-Gel supraglottic airway device

Group Type ACTIVE_COMPARATOR

I-Gel

Intervention Type DEVICE

I-Gel supraglottic airway device

LTS, ETI or other airway practice

Laryngeal tube, endotracheal tube or other current airway management practice

Group Type ACTIVE_COMPARATOR

LTS, ETI or current airway management practice

Intervention Type DEVICE

Laryngeal tube, endotracheal tube, bag-mask-ventilation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

I-Gel

I-Gel supraglottic airway device

Intervention Type DEVICE

LTS, ETI or current airway management practice

Laryngeal tube, endotracheal tube, bag-mask-ventilation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Out-of-hospital cardiac arrest patients requiring and receiving advanced airway management on ambulance missions. Advanced airway management is defined as the attempted insertion of an airway adjunct (I-Gel, laryngeal tube or ETI) or the administration of ventilatory assistance/support (including bag-mask ventilation (BMV) or other ventilatory support.
* Adult patients (\> 18 years).